NUS Stock Analysis: Buy, Sell, or Hold?

NUS - NuSkin Enterprises, Inc.

WHOLESALE-DRUGS, PROPRIETARIES & DRUGGISTS' SUNDRIES
$10.61
-0.03 (-0.28%) ▼
BUY
MODERATE Confidence
Last Updated: January 30, 2026
Earnings: Feb 12, 2026 11d

Get Alerted When NUS Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.
100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading chart...

Loading historical data...

💡
Bottom Line:
💡 BUY OPPORTUNITY: NUS shows positive signals but monitor for confirmation. Market pricing in 1.2% annual growth which appears achievable. Moderate conviction.

Long-Term Wealth Forecast (2031)

Based on Analyst Consensus Growth & Historical Valuation

0% (Stagnation) 50% (Hyper Growth)
EST. PRICE IN 2031
$14.06
Based on 6.6% avg growth
INTRINSIC VALUE TODAY
$8.73
Trading above fair value

How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 7.2x Exit PE.

In-depth Analysis How we analyze

Valuation Analysis: NUS is currently trading at $10.61, which is considered fair relative to its 30-day fair value range of $9.88 to $11.01. The stock's valuation (Forward PE: 7.5) is in line with its historical norms (7.2). At these levels, the market is pricing in 1.2% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.

Technical Outlook: Technically, NUS is in a downtrend. Immediate support is located at $10.00, while resistance sits at $11.67.

Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. However, the stock is trading significantly above the average Wall Street target of $7.50. Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.

Quick Decision Summary

Current Position FAIR
Fair Price Range $9.88 - $11.01
Company Quality Score 50/100 (HOLD)
Options IV Signal 50th percentile (NORMAL)
Volume Confirmation HIGH
Confidence Score 65.0%

All Signals

  • NEUTRAL: Price in fair range
  • NEUTRAL: Options fairly priced (IV 50th percentile)
  • NEUTRAL: Mixed technical signals (40/100)
  • BULLISH: High volume confirmation
  • BEARISH: Trading 29.5% above Wall St target ($7.50)
  • NEUTRAL: Market pricing in 1.2% annual earnings growth - fairly valued

Fair Price Analysis

30-Day Fair Range $9.88 - $11.01
Current vs Fair Value FAIR
Expected Move (7 Days) ±$1.13 (10.6%)

Support & Resistance Levels

Support Level $10.00
Resistance Level $11.67
Current Trend Downtrend

Fundamental Context

Forward P/E (Next Year Est.) 7.49
Wall Street Target $7.50 (-29.5%)
Revenue Growth (YoY) -15.3%
Earnings Growth (YoY) 103.6%
Profit Margin 7.0%
Valuation Premium vs History +1.2% premium
PE vs Historical 7.5 vs 7.2 FAIR
Market-Implied Price Targets If current PE multiple persists
Implied Growth (YoY): +1.2% (market-implied from PE analysis)
1-Year Target $10.77 (+1%)
2-Year Target $10.90 (+2%)
3-Year Target $11.03 (+4%)
3-Yr Target (if PE normalizes) (PE: 7→7) PE COMPRESSION $10.60 (0%)
Earnings growth offset by PE compression
3-Year Scenarios Using analyst projected EPS growth
Bull: (PE: 22.3, Growth: 9.2%) $41.27 (+288%)
Base: (SPY PE: 7.5, Growth: 9.2%) $13.87 (+30%)
Bear: (PE: 6.4, Growth: 9.2%) $11.79 (+11%)
📈 Valuation based on Current Earnings
Trailing PE: 4.47 | Current EPS (TTM): $2.19
Bull Case $6.98 (-34%)
Analyst growth -35.2%, PE expands to 4.9
Base Case $6.34 (-40%)
Market implied -35.2%, PE stable at 4.5
Bear Case $6.65 (-37%)
Severe decline -20.0%, PE contracts to 3.8
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Last updated: January 31, 2026 8:26 AM ET
Data refreshes hourly during market hours. Next update: 9:26 AM
🔥 Top Stocks Breaking Out Now
Ticker Score Recommendation Change %
Insider Activity (6 Months)
0
Buys
4
Sells
Net
INSIDERS SELLING
Recent Transactions
Laura Nathanson SELL 6489 shares 2025-09-04
Chayce David Clark SELL 20000 shares 2025-09-03
Daniel W Campbell SELL 9046 shares 2025-08-29

Top Rated Household & Personal Products Stocks

Top-rated stocks in Household & Personal Products by analyst ratings.

Stock Analyst Consensus Analyst Target Tradestie Score
PG
Procter & Gamble Company
BUY
25 analysts
$167 67 BUY
CL
Colgate-Palmolive Company
BUY
22 analysts
$89 63 BUY
CHD
Church & Dwight Company …
HOLD
24 analysts
$96 61 BUY
ELF
ELF Beauty Inc
STRONG BUY
17 analysts
$112 52 HOLD
EL
Estee Lauder Companies I…
SELL
27 analysts
$110 55 HOLD

Advanced NUS Option Strategies

Professional options setups generated by AI based on today's NUS price and gamma walls.

Iron Condor Bull Call Bear Put Collar

More Analysis for NUS

NUS Technical Chart NUS Price Prediction NUS Earnings Date NUS Investment Advisor NUS Fair Price Analyzer NUS Options Advisor NUS Options Chain NUS Options Analysis NUS Competitors
Live Trades
From trading groups
Loading trades...
View All Live Trades See Trader Consensus & Signals